前收市價 | 0.0100 |
開市 | 0.0200 |
買盤 | 0.0000 |
賣出價 | 0.0000 |
拍板 | 30.00 |
到期日 | 2024-09-20 |
今日波幅 | 0.0100 - 0.0200 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 734 |
Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -61.68% and 1,534%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
J&J (JNJ) beats estimates for fourth-quarter earnings and sales. Sanofi (SNY) is set to acquire Inhibrx's (INBX) rare disease pipeline candidate, INBRX-101.
Gilead Sciences (GILD) and Inhibrx (INBX) are in the spotlight on regulatory and pipeline updates.